Jasper Reports Wider Loss in Fiscal Q2
Jasper Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $0.53
+10% in 3d after detection
Post-detection moves
1h
—
1d
+6.6%
3d
+10%
7d
+1.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS